443 An immunotherapy trio in advanced HNSCC for coordinated B and T cell antigen response
B. Fox(University of Colorado Boulder), Hong‐Ming Hu(Viva Biotech (China)), Christopher Paustian(UbiVac (United States)), Noriko Iwamoto(Shimadzu (Japan)), Marcus Couey(Providence Portland Medical Center), Tarsem Moudgil(Providence Portland Medical Center), Fridtjof Lund‐Johansen(Oslo University Hospital), Madeleine Laws(UbiVac (United States)), Walter J. Urba(Providence Portland Medical Center), R. Bryan Bell(Takara (United States)), Shawn M. Jensen(Providence Portland Medical Center), Carlo Bifulco(Providence Health & Services), Rom S. Leidner(Providence Portland Medical Center), Glenna McDonnell(UbiVac (United States)), Traci Hilton(UbiVac (United States)), Yoshinobu Koguchi(Providence Portland Medical Center), Brian Piening(Providence College), Carmen Ballesteros Merino(Providence Portland Medical Center), Takashi Shimada(Keio University), Rachel E. Sanborn(Providence Portland Medical Center), Adi Mehta(Oslo University Hospital)
Cited by 0
Related Papers
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
|Journal of Clinical Investigation|2004|1.4k
The NASA Twins Study: A multidimensional analysis of a year-long human spaceflight
|Science|2019|1.1k
Cancer classification using the Immunoscore: a worldwide task force
|Journal of Translational Medicine|2012|803
Longitudinal multi-omics of host–microbe dynamics in prediabetes
|Nature|2019|620